Inflammation types and molecular causes of allergic bronchopulmonary aspergillosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational cohort study enrolling patients who meet diagnostic criteria for allergic bronchopulmonary aspergillosis or fungal‑sensitized asthma. Researchers will collect clinical data and biological samples, including procedures that may involve bronchoscopy, to profile immune and inflammatory molecular signatures. The goal is to define inflammation-based subtypes (precision typing), identify biomarkers that mark those subtypes, and correlate each phenotype with clinical outcomes. The work is conducted by Qianfoshan Hospital in collaboration with Shanghai Pulmonary Hospital, Fudan University, and Guizhou Provincial People's Hospital.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Meets the diagnostic criteria for allergic bronchopulmonary aspergillosis.
* Meets the diagnostic criteria for fungal-sensitized asthma.

Exclusion Criteria:

* Human immunodeficiency virus infection.
* Malignant tumor.
* Blood system disease.
* autoimmune system disease.
* History of pulmonary tuberculosis.
* Patients with a history of smoking or still smoking.
* Invasive pulmonary fungal disease.
* Contraindications electronic bronchoscopy

Where it's running

• Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China
  Jinan, Shandong, China Recruiting

Study contacts

• Study coordinator: Qian Qi, Prof.
• Email: qiqianqlh@163.com
• Phone: +86 13706380314

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ML-based ABPA recurrence predictor in adults with ABPA

  A machine-learning model is being tested to see if it can predict the chance of an ABPA flare within a year in adults with ABPA during a stable phase.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07714863

• Fungal status and prognosis in ABPA: looking at who improves based on fungal tests

  This study checks if ABPA patients with positive or negative fungal tests in sputum or BALF have different outcomes over a year.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07690345

• Can a multi-omics and AI model predict ABPA relapse within 1 year in adults?

  This study tests a machine learning model that uses multi-omics and clinical data to predict the 1-year relapse risk for adults with ABPA who are in a stable state.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07611838

• Immune status and disease control in airway inflammatory diseases

  This project will test whether specific blood immune cell patterns relate to disease control in adults with asthma, COPD, bronchiectasis, or obstructive sleep apnea by comparing them with healthy volunteers.

  Recruiting First Affiliated Hospital of Ningbo University · Ningbo, Zhejiang · NCT07493629

• Biologic treatment for adults with ABPA and severe asthma

  This project will test whether biologic medicines help adults with ABPA who have severe asthma and elevated eosinophils.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07362693

• Bronchoscopic airway clearance with amphotericin B spraying for ABPA

  This study will try bronchoscopic airway clearance plus amphotericin B spraying to see if it helps adults with allergic bronchopulmonary aspergillosis (ABPA) who have mucus plugs.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07362667

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.